Company / Working Capital
BioLife Solutions, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$113.6M
FY2025
5-year range
$78.4M / $116.0M
FY2021-FY2025
Trend
-2.1%
vs FY2024
Sector context
#134 of 165
Health Care
What the data says
BioLife Solutions, Inc.'s working capital of $114M is lower than 81% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $3M in FY2016 to $116M in FY2024.
Based on SEC 10-K filings.
$114M in FY2025 with a 5-year CAGR of +2.8%.
Improved from $78M to $114M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 165This company $113.6M Sector average $836.2M
▼
-86.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.8%, indicating consistent growth.
- In FY2025, working capital decreased 2.1% year-over-year.
- Ranks #134 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.6M | -2.1% |
| FY2024 | $116.0M | +47.9% |
| FY2023 | $78.4M | -16.5% |
| FY2022 | $93.9M | +12.6% |
| FY2021 | $83.4M | -15.9% |
| FY2020 | $99.1M | +502.9% |
| FY2019 | $16.4M | +84.1% |
| FY2018 | $8.9M | +6.1% |
| FY2017 | $8.4M | +140.9% |
| FY2016 | $3.5M | -33.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026